|
Home |
Business News |
Browse by Publication |
P |
PR Newswire
|
ImaginAb, Inc. and BZL Biologics, LLC Conclude Licensing Agreement for Imaging Rights to huJ591/Prostate-Specific Membrane Antigen (PSMA).
Publication:
PR Newswire
Publication Date: 12-OCT-09 |
Format: Online Delivery: Immediate Online Access |
|
|
|
|
Article Excerpt A collaborative licensing relationship to develop prostate cancer imaging agents based on engineered antibody fragments
INGLEWOOD, Calif., Oct. 12 /PRNewswire/ -- ImaginAb, Inc. and BZL Biologics, LLC have concluded a sublicense of BZL's PSMA/huJ591 antibody technology for the field of diagnostic imaging for PET and SPECT. "ImaginAb is pleased to have completed this [sub]licensing agreement with BZL as we...
|
|
Read the FULL article now -
Try Goliath Business News - FREE!
You can view this article PLUS...
-
Over 5 million business articles
-
Hundreds of the most trusted magazines, newswires, and journals
(see list)
-
Premium business information that is timely and relevant
-
Unlimited Access
|
Now for a Limited Time, try Goliath Business News - Free for 3 Days!
|
|
|
|
|
 |
|

Looking for additional articles?
Search our database of over 3 million articles.
Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication
name or publication date.
About Goliath
Whether you're looking for sales prospects, competitive information, company
analysis or best practices in managing your organization,
Goliath can help you meet your business needs.
Our extensive business information databases empower business
professionals with both the breadth and depth of credible,
authoritative information they need to support their business
goals. Whether it be strategic planning, sales prospecting,
company research or defining management best practices -
Goliath is your leading source for accurate information.
|
|
|